Buxboim Amnon, Bar-Dagan Maya, Frydman Veronica, Zbaida David, Morpurgo Margherita, Bar-Ziv Roy
Departments of Materials and Interfaces, The Weizmann Institute of Science, PO Box 26, Rehovot 76100, Israel.
Small. 2007 Mar;3(3):500-10. doi: 10.1002/smll.200600489.
We have developed a biochip platform technology suitable for controlled cell-free gene expression at the micrometer scale. A new hybrid molecule, "Daisy", was designed and synthesized to form in a single step a biocompatible lithographic interface on silicon dioxide. A protocol is described for the immobilization of linear DNA molecules thousands of base pairs long on Daisy-coated surfaces with submicrometer spatial resolution and up to high densities. On-chip protein synthesis can be obtained with a dynamic range of up to four orders of magnitude and minimal nonspecific activity. En route to on-chip artificial gene circuits, a simple two-stage gene cascade was built, in which the protein synthesized at the first location diffuses to regulate the synthesis of another protein at a second location. We demonstrate the capture of proteins from crude extract onto micrometer-scale designated traps, an important step for the formation of miniaturized self-assembled protein chips. Our biochip platform can be combined with elastomeric microfluidic devices, thereby opening possibilities for isolated and confined reaction chambers and artificial cells in which the transport of products and reagents is done by diffusion and flow. The Daisy molecule and described approach enables groups not proficient in surface chemistry to construct active biochips based on cell-free gene expression.
我们开发了一种适用于在微米尺度上进行可控无细胞基因表达的生物芯片平台技术。设计并合成了一种新型杂合分子“雏菊”,以便在一步反应中在二氧化硅上形成生物相容性光刻界面。本文描述了一种方法,可将数千个碱基对长的线性DNA分子以亚微米空间分辨率和高达高密度固定在涂有雏菊的表面上。芯片上的蛋白质合成动态范围可达四个数量级,非特异性活性极低。在构建芯片上的人工基因电路的过程中,构建了一个简单的两阶段基因级联,其中在第一个位置合成的蛋白质扩散到第二个位置以调节另一种蛋白质的合成。我们展示了将粗提物中的蛋白质捕获到微米级指定捕集器上的过程,这是形成小型化自组装蛋白质芯片的重要一步。我们的生物芯片平台可与弹性体微流控装置相结合,从而为隔离和受限的反应室以及人工细胞开辟了可能性,在这些反应室和人工细胞中,产物和试剂的传输通过扩散和流动来完成。雏菊分子及所描述的方法使不精通表面化学的团队能够基于无细胞基因表达构建活性生物芯片。